Social Europe

  • EU Forward Project
  • YouTube
  • Podcast
  • Books
  • Newsletter
  • Membership

The false scarcity of vaccine trade tensions

Katie Gallogly-Swan 8th February 2021

The row over the EU introducing vaccine export controls has occluded its rejection of a temporary waiver on intellectual property rights.

intellectual property rights,private patents
Katie Gallogly-Swan

As we approach the anniversary of the pandemic’s declaration by the World Health Organization, health and care systems around the world are being rocked by a second wave of cases, dwarfing the first surge last spring.

In the initial stages of the pandemic, the fear of the impact on national populations led to more than 100 export controls around the world for crucial medicines and medical equipment. Understandably, governments moved to protect their own citizens but the lack of co-ordination resulted in an inefficient distribution of these vital supplies, hindering global capacity to stem surges at their root.

Responding to such trade controls within the European Union, the European Commission president, Ursula von der Leyen, told the European Parliament last March that ‘a crisis without borders cannot be resolved by putting barriers between us’.

Against this experience, the commission’s announcement on January 29th of new export controls on vaccines surprised many around the world—drawing criticism from key allies, the WHO and indeed von der Leyen’s predecessor, Jean-Claude Juncker. While the commission put this down to a breach of contract obligations, the resounding impression given was of putting European citizens first in the scramble to secure vaccines, when the global nature of the pandemic meant nation-first approaches were doomed to fail.

Waiver blocked

Yet the idea that the EU was prioritising access for its own citizens was itself flawed, since alongside wealthy individual states, such as the United States, the United Kingdom, Japan and Australia, it continues to block a temporary waiver on intellectual property rights for Covid-19 vaccines, which is backed by most members of the World Trade Organization. Such a waiver would make the patents, industrial designs and trade secrets used to make Covid-19 vaccines global public goods—meaning more vaccines to distribute at less cost to public coffers around the world.

UNICEF figures reveal that only 43 per cent of reported Covid-19 vaccine production capacity is currently being used for the approved vaccines. According to the People’s Vaccine campaign, the three biggest manufacturers in the world are only producing vaccines for about 1.5 per cent of the global population—much less than their total capacity if patents did not stand in the way.

Last week, the Danish company Bavarian Nordic offered to manufacture up to 240 million vaccines in its newly-built facilities but this offer is yet to be taken up by any of the major vaccine companies. While wealthy countries have bought up most of the first stocks of viable vaccine candidates, there is also untapped production potential across different regions, with 20 more vaccine manufacturers in India alone.

Private patents

At the current rate of vaccination, it will take seven years for enough of the world to be vaccinated to prevent further transmission. Seven years is a long time for the virus to mutate and build resistance to currently viable vaccinations—a risk recently highlighted by the emergence of new strains. With the looming risk of reinfection with a more deadly or contagious version of the virus, it is paramount that every tool at our disposal is oriented to producing enough vaccines to eradicate it swiftly everywhere.

Artificial rationing is what is driving vaccine nationalism, yet the EU again blocked the waiver at the Trade Related Intellectual Property Rights Council meeting at the WTO last Thursday, claiming that private patents were needed to encourage innovation. As others have pointed out, however, much of the industry’s innovation has been predicated on decades of public support for research and development. Indeed, governments around the world have invested €88.3 billion in Covid-19 vaccine development so far.

For citizens of countries with the fiscal space to support such investments, this amounts to paying for the vaccine three times: when their government supported vaccine development, when it bought stocks and when it funds the COVAX facility intended to secure vaccines for poorer countries pushed out of the race. While the EU and other wealthy regions have borne the brunt of the public-health challenge, with the vast majority of cases and deaths, a recent study has found that failing to vaccinate people in low-income countries will have the worst economic impact on wealthy economies.

Unleash production

A waiver on intellectual property would see a drastic decrease in the cost of vaccination for all governments, with more regional production unleashed across the world. This is not simply a case of high-income countries versus low-income but of patent monopolies, propped up by a few WTO members, versus the safety of everyone.

The EU and others blocking the waiver have chosen to back these pharmaceutical-company monopolies over their own public health and any hope of a rapid, global vaccination programme. The same companies shunned the voluntary Covid-19 Technology Access Pool launched by the WHO early in the pandemic—the head of Pfizer calling the initiative ‘nonsense’—while making billions in profit from Covid-19 vaccines.

Keeping the patents of Covid-19 vaccines secret offers no demonstrable public benefit to the global pandemic effort. Instead, it is leading to chauvinistic policy choices which erode co-operation and trust and prolong the pandemic for everyone.

Katie Gallogly Swan
Katie Gallogly-Swan
Katie Gallogly-Swan works on climate and development at the United Nations Conference on Trade and Development. Previously, she worked at Boston University’s Global Development Policy Center, on how trade, development finance and climate policy can enable a global just transition, and at Oxfam and ActionAid, on economic, climate and gender policy.

Harvard University Press Advertisement

Social Europe Ad - Promoting European social policies

We need your help.

Support Social Europe for less than €5 per month and help keep our content freely accessible to everyone. Your support empowers independent publishing and drives the conversations that matter. Thank you very much!

Social Europe Membership

Click here to become a member

Most Recent Articles

u421983467298feb62884 0 The Weak Strongman: How Trump’s Presidency Emboldens America’s EnemiesTimothy Snyder
u4201 af20 c4807b0e1724 3 Ballots or Bans: How Should Democracies Respond to Extremists?Katharina Pistor
u421983c824 240f 477c bc69 697bf625cb93 1 Mind the Gap: Can Europe Afford Its Green and Digital Future?Viktor Skyrman
u421983467b5 5df0 44d2 96fc ba344a10b546 0 Finland’s Austerity Gamble: Tax Cuts for the Rich, Pain for the PoorJussi Systä
u421983467 3f8a 4cbb 9da1 1db7f099aad7 0 The Enduring Appeal of the Hybrid WorkplaceJorge Cabrita

Most Popular Articles

startupsgovernment e1744799195663 Governments Are Not StartupsMariana Mazzucato
u421986cbef 2549 4e0c b6c4 b5bb01362b52 0 American SuicideJoschka Fischer
u42198346769d6584 1580 41fe 8c7d 3b9398aa5ec5 1 Why Trump Keeps Winning: The Truth No One AdmitsBo Rothstein
u421983467 a350a084 b098 4970 9834 739dc11b73a5 1 America Is About to Become the Next BrexitJ Bradford DeLong
u4219834676ba1b3a2 b4e1 4c79 960b 6770c60533fa 1 The End of the ‘West’ and Europe’s FutureGuillaume Duval
u421983462e c2ec 4dd2 90a4 b9cfb6856465 1 The Transatlantic Alliance Is Dying—What Comes Next for Europe?Frank Hoffer
u421983467 2a24 4c75 9482 03c99ea44770 3 Trump’s Trade War Tears North America Apart – Could Canada and Mexico Turn to Europe?Malcolm Fairbrother
u4219834676e2a479 85e9 435a bf3f 59c90bfe6225 3 Why Good Business Leaders Tune Out the Trump Noise and Stay FocusedStefan Stern
u42198346 4ba7 b898 27a9d72779f7 1 Confronting the Pandemic’s Toxic Political LegacyJan-Werner Müller
u4219834676574c9 df78 4d38 939b 929d7aea0c20 2 The End of Progess? The Dire Consequences of Trump’s ReturnJoseph Stiglitz

S&D Group in the European Parliament advertisement

Cohesion Policy

S&D Position Paper on Cohesion Policy post-2027: a resilient future for European territorial equity”,

Cohesion Policy aims to promote harmonious development and reduce economic, social and territorial disparities between the regions of the Union, and the backwardness of the least favoured regions with a particular focus on rural areas, areas affected by industrial transition and regions suffering from severe and permanent natural or demographic handicaps, such as outermost regions, regions with very low population density, islands, cross-border and mountain regions.

READ THE FULL POSITION PAPER HERE

ETUI advertisement

HESA Magazine Cover

What kind of impact is artificial intelligence (AI) having, or likely to have, on the way we work and the conditions we work under? Discover the latest issue of HesaMag, the ETUI’s health and safety magazine, which considers this question from many angles.

DOWNLOAD HERE

Eurofound advertisement

Ageing workforce
How are minimum wage levels changing in Europe?

In a new Eurofound Talks podcast episode, host Mary McCaughey speaks with Eurofound expert Carlos Vacas Soriano about recent changes to minimum wages in Europe and their implications.

Listeners can delve into the intricacies of Europe's minimum wage dynamics and the driving factors behind these shifts. The conversation also highlights the broader effects of minimum wage changes on income inequality and gender equality.

Listen to the episode for free. Also make sure to subscribe to Eurofound Talks so you don’t miss an episode!

LISTEN NOW

Foundation for European Progressive Studies Advertisement

Spring Issues

The Spring issue of The Progressive Post is out!


Since President Trump’s inauguration, the US – hitherto the cornerstone of Western security – is destabilising the world order it helped to build. The US security umbrella is apparently closing on Europe, Ukraine finds itself less and less protected, and the traditional defender of free trade is now shutting the door to foreign goods, sending stock markets on a rollercoaster. How will the European Union respond to this dramatic landscape change? .


Among this issue’s highlights, we discuss European defence strategies, assess how the US president's recent announcements will impact international trade and explore the risks  and opportunities that algorithms pose for workers.


READ THE MAGAZINE

Hans Böckler Stiftung Advertisement

WSI Report

WSI Minimum Wage Report 2025

The trend towards significant nominal minimum wage increases is continuing this year. In view of falling inflation rates, this translates into a sizeable increase in purchasing power for minimum wage earners in most European countries. The background to this is the implementation of the European Minimum Wage Directive, which has led to a reorientation of minimum wage policy in many countries and is thus boosting the dynamics of minimum wages. Most EU countries are now following the reference values for adequate minimum wages enshrined in the directive, which are 60% of the median wage or 50 % of the average wage. However, for Germany, a structural increase is still necessary to make progress towards an adequate minimum wage.

DOWNLOAD HERE

Social Europe

Our Mission

Team

Article Submission

Advertisements

Membership

Social Europe Archives

Themes Archive

Politics Archive

Economy Archive

Society Archive

Ecology Archive

Miscellaneous

RSS Feed

Legal Disclosure

Privacy Policy

Copyright

Social Europe ISSN 2628-7641